Correlates of treatment response in depressed older adults with bipolar disorder

Journal of Geriatric Psychiatry and Neurology

Volumn 25, Issue 1, 2012, Pages 37-42

  Gildengers, Ariel ^a   Tatsuoka, Curtis ^b   Bialko, Christopher ^b   Cassidy, Kristin A ^b   Al Jurdi, Rayan K ^c   Gyulai, Laszlo ^d   Mulsant, Benoit H ^e   Young, Robert C ^f   Sajatovic, Martha ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

anticonvulsant; bipolar disorder; depression; elderly; geriatric; lamotrigine; mood stabilizer

Indexed keywords

CHOLESTEROL; LAMOTRIGINE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CUMULATIVE ILLNESS RATING SCALE GERIATRIC; DRUG DOSE TITRATION; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; RATING SCALE; TREATMENT RESPONSE; YOUNG MANIA RATING SCALE;

AGED; AGED, 80 AND OVER; ANTIMANIC AGENTS; BIPOLAR DISORDER; CHOLESTEROL; DEPRESSIVE DISORDER; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME; TRIAZINES;

EID: 84859342690     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988712436685     Document Type: Article

References (41)

1. Judd LL, Akiskal HS, Schettler PJ, et al. The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder. Arch Gen Psychiatry. June 1, 2002 2002;59(6):530-537.
2. Altshuler LL, Gitlin MJ, Mintz J, Leight KL, Frye MA. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry. Sep 2002;63(9):807-811.
3. Vieta E, Benabarre A, Colom F, et al. Suicidal behavior in bipolar I and bipolar II disorder. J Nerv Ment Dis. Jun 1997;185(6):407-409. (Pubitemid 27293527)
4. Depp CA, Jeste DV. Bipolar disorder in older adults: a critical review. Bipolar Disord. Oct 2004;6(5):343-367. (Pubitemid 39345286)
5. Depp CA, Davis CE, Mittal D, Patterson TL, Jeste DV. Health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder. J Clin Psychiatry. Feb 2006;67(2):215-221. (Pubitemid 43357467)
6. Post RM, Denicoff KD, Leverich GS, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry. Jun 2003;64(6):680-690; quiz 738-689.
7. Judd LL, Akiskal HS, Schettler PJ, et al. Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry. Dec 2005;62(12):1322-1330. (Pubitemid 41746610)
8. Kupka RW, Altshuler LL, Nolen WA, et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord. Aug 2007;9(5):531-535. (Pubitemid 47202517)
9. Kapczinski F, Vieta E, Andreazza AC, et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008;32(4):675-692.
10. Young AH, Macritchie KAN. Adverse syndromes associated with lithium. In: Haddad P, Dursun S, Deakin B, eds. Adverse Syndromes and Psychiatric Drugs: A Clinical Guide. New York, NY: Oxford University Press; 2004:89-124.
11. Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D. Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials. Bipolar Disord. Sep 2007;9(6):551-560. (Pubitemid 47365622)
12. Young RC, Gyulai L, Mulsant BH, et al. Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am J Geriatr Psychiatry. Jul-Aug 2004;12(4):342-357. (Pubitemid 38878855)
13. Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. Oct 2005;162(10):1805-1819. (Pubitemid 41428610)
14. Nunes PV, Forlenza OV, Gattaz WF. Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br J Psychiatry. Apr 2007;190(4):359-360. (Pubitemid 46580688)
15. Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ. Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry. Nov 2009;70(11):1588-1597.
16. Jeste DV, Jin H, Golshan S, et al. Discontinuation of quetiapine from an NIMH-funded trial due to serious adverse events. Am J Psychiatry. Aug 2009;166(8):937-938.
17. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. Apr 2002;159(4 Suppl):1-50.
18. Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. May 2009;11(3):225-255.
19. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. Apr 26 2007;356(17):1711-1722. (Pubitemid 46658703)
20. SajatovicM, Gildengers A, Al Jurdi RK, et al.Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary report. Bipolar Disord. May 2011;13(3):294-302.
21. Montgomery SA, AsbergM. A new depression scale designed to be sensitive to change. Br J Psychiatry. Apr 1979;134(4):382-389. (Pubitemid 9136500)
22. Frye MA, Watzl J, Banakar S, et al. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology. Dec 2007;32(12):2490-2499. (Pubitemid 350126840)
23. Dager SR, Friedman SD, Parow A, et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry. May 2004;61(5):450-458. (Pubitemid 38620843)
24. Payne JL, Quiroz JA, Zarate CA, Jr., Manji HK. Timing is everything: does the robust upregulation of noradrenergically regulated plasticity genes underlie the rapid antidepressant effects of sleep deprivation? Biol Psychiatry. Nov 15 2002;52(10):921-926. (Pubitemid 35363293)
25. Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. Jan 2011;35(3):804-817.
26. Manji HK, Quiroz JA, Sporn J, et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry. Apr 15 2003;53(8):707-742. (Pubitemid 39658487)
27. Sanacora G. Do glutamatergic agents represent a new class of antidepressant drugs? Part 2. J Clin Psychiatry. Nov 2009;70(11):1604-1605.
28. Kemp DE, Gao K, Chan PK, Ganocy SJ, Findling RL, Calabrese JR. Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord. Jun 2010;12(4):404-413.
29. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. Feb 1960;23(1):56-62.
30. Williams JB, Kobak KA, Bech P, et al. The GRID-HAMD: standardization of the Hamilton Depression Rating Scale. Int Clin Psychopharmacol. May 2008;23(3):120-129. (Pubitemid 351535903)
31. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry. 1978;133(5):429-435. (Pubitemid 9006756)
32. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Research. 1992;41(3):237-248.
33. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Tucson, Arizon: Neuropsychology Press; 1993.
34. Leboyer M, Kupfer DJ. Bipolar disorder: new perspectives in health care and prevention. J Clin Psychiatry. Dec 2010;71(12):1689-1695.
35. Sheline YI, Pieper CF, Barch DM, et al. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry. Mar 2010;67(3):277-285.
36. Bearden CE, Woogen M, Glahn DC. Neurocognitive and neuroimaging predictors of clinical outcome in bipolar disorder. Curr Psychiatry Rep. Dec 2010;12(6):499-504.
37. Moore PB, Shepherd DJ, Eccleston D, et al. Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Br J Psychiatry. Feb 2001;178(2):172-176. (Pubitemid 32158081)
38. Regenold WT, Hisley KC, Phatak P, et al. Relationship of cerebrospinal fluid glucose metabolites to MRI deep white matter hyperintensities and treatment resistance in bipolar disorder patients. Bipolar Disord. Nov 2008;10(7):753-764.
39. Sneed JR, Culang-Reinlieb ME. The vascular depression hypothesis: an update. Am J Geriatr Psychiatry. Feb 2011;19(2):99-103.
40. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. March 1, 1991 1991;22(3):312-318.
41. Judd LL, Akiskal HS, Schettler PJ, et al. A Prospective Investigation of the Natural History of the Long-term Weekly Symptomatic Status of Bipolar II Disorder. Arch Gen Psychiatry. March 1, 2003 2003;60(3):261-269.